At the Richard T. Silver Myeloproliferative Neoplasms (MPN) Center at Weill Cornell Medicine and NewYork-Presbyterian Hospital, our expert team is equipped to accurately diagnose, treat and manage all common and rare MPNs – including, but not limited to, chronic myeloid leukemia (CML), essential thrombocythemia (ET), myelofibrosis (MF) and polycythemia vera (PV). We are committed to advancing cures through innovative research and cutting-edge clinical trials.
Watch to learn more about the compassionate, state-of-the-art care offered to patients at the Silver MPN Center.